We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
-3.82%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.14B
AUM Growth
-$348M
Cap. Flow
-$183M
Cap. Flow %
-8.54%
Top 10 Hldgs %
19.87%
Holding
278
New
28
Increased
51
Reduced
132
Closed
33

Top Buys

Rank Stock Value
1
AJRD
Aerojet Rocketdyne Holdings
AJRD
+$15.9M
2
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$15.8M
3
VIAV icon
Viavi Solutions
VIAV
+$15.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$12.5M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$9.83M

Top Sells

Rank Stock Value
1
CRAY
Cray, Inc.
CRAY
+$24.4M
2
IOSP icon
Innospec
IOSP
+$18.8M
3
TDOC icon
Teladoc Health
TDOC
+$15.8M
4
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$11.6M
5
SAVE
Spirit Airlines, Inc.
SAVE
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 21.41%
2 Industrials 17.43%
3 Consumer Discretionary 17.37%
4 Technology 13.96%
5 Financials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PNFP icon
51
Pinnacle Financial Partners Inc
PNFP
$15.3B
$16M 0.75%
+282,400
New +$15.8M
MC icon
52
Moelis & Co
MC
$5.02B
$15.6M 0.73%
474,325
-43,802
-8% -$1.49M
VIAV icon
53
Viavi Solutions
VIAV
$9.41B
$14.9M 0.7%
+1,064,563
New +$15.1M
CSFL
54
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$14.9M 0.7%
620,627
-142,004
-19% -$3.32M
QTWO icon
55
Q2 Holdings
QTWO
$3.43B
$14.7M 0.69%
186,062
-115,672
-38% -$9.56M
KPTI icon
56
Karyopharm Therapeutics
KPTI
$216M
$14.4M 0.67%
99,772
+1,356
+1% +$184K
NFE icon
57
New Fortress Energy
NFE
$102M
$14.2M 0.67%
790,020
-67,029
-8% -$960K
ALRM icon
58
Alarm.com
ALRM
$2.63B
$14M 0.65%
299,949
-24,561
-8% -$1.2M
LIVN icon
59
LivaNova
LIVN
$4.43B
$13.7M 0.64%
185,069
+25,521
+16% +$1.97M
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$13.4M 0.63%
501,464
-35,406
-7% -$994K
TWST icon
61
Twist Bioscience
TWST
$5.84B
$13.4M 0.63%
560,707
-18,894
-3% -$549K
MNR
62
DELISTED
Monmouth Real Estate Investment Corp
MNR
$13.3M 0.62%
925,291
-90,017
-9% -$1.23M
ZGNX
63
DELISTED
Zogenix, Inc.
ZGNX
$13.3M 0.62%
332,958
-28,037
-8% -$1.29M
BHVN
64
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$13.2M 0.62%
316,646
-21,004
-6% -$887K
ARNA
65
DELISTED
Arena Pharmaceuticals Inc
ARNA
$13.2M 0.62%
287,899
-137,611
-32% -$7.74M
EHTH icon
66
eHealth
EHTH
$47.3M
$13.1M 0.61%
195,894
-50,652
-21% -$4.57M
VNOM icon
67
Viper Energy
VNOM
$8.66B
$13M 0.61%
470,045
-45,917
-9% -$1.37M
AIMT
68
DELISTED
Aimmune Therapeutics
AIMT
$12.8M 0.6%
610,511
-230,020
-27% -$4.7M
TENB icon
69
Tenable Holdings
TENB
$4.4B
$12.6M 0.59%
565,077
+1,297
+0.2% +$32.9K
GLUU
70
DELISTED
Glu Mobile Inc.
GLUU
$12.6M 0.59%
2,522,844
-210,670
-8% -$1.21M
PTCT icon
71
PTC Therapeutics
PTCT
$6.52B
$12.6M 0.59%
371,908
-16,102
-4% -$701K
DRNA
72
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$12.5M 0.59%
873,609
-113,048
-11% -$1.62M
MMSI icon
73
Merit Medical Systems
MMSI
$4.41B
$12.5M 0.58%
409,252
+155,645
+61% +$6.3M
ECVT icon
74
Ecovyst
ECVT
$1.41B
$11.7M 0.55%
734,091
-54,877
-7% -$839K
VCEL icon
75
Vericel Corp
VCEL
$2.38B
$11.5M 0.54%
756,789
-21,444
-3% -$375K
1 2
3
4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Emerald Advisers held 278 positions worth $2.14B, down 14% from $2.49B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers withdrew a net $183M in Q3 2019, closing 33 positions and reducing 132 holdings. Its most notable exit was Cray, Inc., an estimated $24.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Emerald Advisers opened a new position in Aerojet Rocketdyne Holdings worth $16.5M.

  • Emerald Advisers's largest Q3 2019 buy was Aerojet Rocketdyne Holdings: 327,583 shares worth $16.5M.
  • Emerald Advisers added most to Pluralsight, Inc. Class A Common Stock in Q3 2019, an estimated $9.83M increase.
  • Emerald Advisers's biggest Q3 2019 reduction was Teladoc Health, cutting an estimated $15.8M.
  • Emerald Advisers fully exited Cray, Inc. in Q3 2019, selling an estimated $24.4M.
  • Emerald Advisers's ten largest holdings make up 20% of its $2.14B portfolio in Q3 2019.
  • Emerald Advisers opened 28 new positions and closed 33 in Q3 2019.
  • Emerald Advisers's portfolio value fell 14% quarter-over-quarter to $2.14B.

Based on Emerald Advisers's 13F filing for Q3 2019, filed 31 Oct 2019.